UROTHERAPY FOR PATIENTS WITH CANCER

Joseph Eldor, MD

Theoretical Medicine Institute
P.O.Box 12142, Jerusalem, 91120,Israel
E-mail: a1b2c3d4@netvision.net.il

Subcutaneous urine injections was practiced in 1912 by
Duncan (1) from New York under the name of auto-pyotherapy
for urinary infections, and in 1919 by Wildbolz (1) from
Bern for diagnostic purposes. Cimino (2) from Palermo
reported in 1927 on the use of auto uro-therapy for urinary
infections. Rabinowitch (3) in 1931 described this
auto-urine therapy for gonarthritis. Jausion et al. (4)
used this kind of therapy in 1933 for desensitization and
endocrinological problems. They treated with auto urotherapy
injections patients who suffered from migraine, pruritus,
asthma, urticaria, eczema, psoriasis, etc. Day (5)in 1936
treated patients with acute and subacute glomerulonephritis
by injection of an autogenous urinary extract. Sandweiss,
Saltzstein and Farbman (6) reported in 1938 that an extract
from urine of pregnant women has a prophylactic and
therapeutic effect on experimental ulcers in dogs. Shortly
thereafter the same group noted that an extract from urine
of normal women has a similar beneficial effect (7).
In 1926 Seiffert first described the construction of ileal
loop conduits for urinary diversion (8). Bricker in the
1950s popularized the use of the ileal loop as a means of
supravesical urinary diversion following exenteration for
pelvic malignancy in adults (9). Ureterosigmoidostomy as a
means of urinary diversion was used widely from 1920 to
1955. It was this type of implant which Hammer first
reported in 1929 associated with tumor (10).